← Back to Clinical Trials
Recruiting NCT07035951

NCT07035951 The VIP3 (Very Old Intensive Care Patients) Study: Family Involvement in Treatment Decisions for Old ICU Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07035951
Status Recruiting
Phase —
Sponsor St George's, University of London
Condition Family Members
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2025-06-16
Primary Completion 2027-06-01

Eligibility & Interventions

Sex All sexes
Min Age 75 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2025-06-16 with a primary completion date of 2027-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The demographics of the global population is changing with increasing numbers of elderly and co-morbid patients. As a result, more elderly patients will be admitted to the Intensive Care Unit (ICU), which will bring several ethical challenges. It is for this reason the investigators have chosen to focus on this historically neglected and important patient population. Little is known about how family meetings are implemented in ICUs in Europe and other parts of the world. However, these meetings contribute to building trust between the family and the ICU team. They are a crucial component for planning and conducting a time limited trials as they provide the opportunity for shared-decision making with the ICU team and with other stakeholders. The investigators plan to determine the current practice of communication between ICU staff and patients and their relatives. The investigators expect to find a substantial variation in approaches to family meetings. This information may then help design and further investigate targeted interventions enabling shared decision-making focused on family and patient values. The investigators research aim is to to investigate whether Family meetings are used in ICUs across Europe and other regions and, if so, how they are conducted and the influence on patient-centred outcome measures.

Eligibility Criteria

Inclusion Criteria: * Patients admitted to the Intensive Care Unit (ICU) of participating centres * Age 75 years and above * Expected Length of stay (LOS) \> 3 days Exclusion Criteria: * Refusal to participate * Limitation of treatment upon ICU arrival (other than Cardiopulmonary Resuscitation-CPR) * Planned admission

Contact & Investigator

Central Contact

Nikki Yun

✉ vip3.study@stgeorges.nhs.uk

📞 +44208 725 0249

Principal Investigator

Susannah Leaver, PhD FRCP FICM

PRINCIPAL INVESTIGATOR

St George's Hospital

Frequently Asked Questions

Who can join the NCT07035951 clinical trial?

This trial is open to participants of all sexes, aged 75 Years or older, studying Family Members. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07035951 currently recruiting?

Yes, NCT07035951 is actively recruiting participants. Contact the research team at vip3.study@stgeorges.nhs.uk for enrollment information.

Where is the NCT07035951 trial being conducted?

This trial is being conducted at London, United Kingdom.

Who is sponsoring the NCT07035951 clinical trial?

NCT07035951 is sponsored by St George's, University of London. The principal investigator is Susannah Leaver, PhD FRCP FICM at St George's Hospital. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology